Teneligliptin 20mg + Metformin 500mg SR Tablet in PCD pharma franchise in Hyderabad

Teneligliptin 20mg + Metformin 500mg SR Tablet in pharmaceutical manufacturing company in Mumbai

Teneligliptin 20mg + Metformin 500mg SR Tablet in antidiabetic pharma franchise in Pune

Teneligliptin 20mg + Metformin 500mg SR Tablet in pharma suppliers in Delhi

Teneligliptin 20mg + Metformin 500mg SR Tablet in pharma export companies in Kolkata
Teneligliptin 20mg + Metformin 500mg SR Tablet in pharma franchise opportunities in Bengaluru

Home/Products /tenlegliptin-hcl-500mg-s-point-r-bi-layered-tablets

About the Product

Description


Tengroup M SR Tablet is a bi-layered formulation combining Teneligliptin 20mg, a potent DPP-4 inhibitor, with Metformin 500mg (sustained release), a well-established biguanide antidiabetic agent. This combination provides a complementary dual action to effectively control blood glucose levels in patients with type 2 diabetes mellitus. Teneligliptin enhances incretin hormone activity, increasing insulin secretion and decreasing glucagon release in a glucose-dependent manner, while Metformin reduces hepatic glucose production and improves peripheral insulin sensitivity. The sustained-release form of Metformin ensures a gradual and steady release, minimizing gastrointestinal side effects and improving patient compliance. Tenelit M supports better glycemic control without significant risk of hypoglycemia or weight gain, making it an effective option in comprehensive diabetes management alongside diet and exercise.

Common side effects include mild gastrointestinal discomfort such as nausea, diarrhea, and abdominal pain due to Metformin. Teneligliptin is generally well tolerated but may cause headache or nasopharyngitis. Hypoglycemia risk is low but may increase when combined with other glucose-lowering agents.

Indicated for the treatment of type 2 diabetes mellitus, particularly when diet and exercise alone do not provide adequate glycemic control. It can be used as monotherapy or in combination with other antidiabetic agents.

Not recommended for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment. Regular monitoring of renal function and blood glucose levels is advised. Use caution in patients with hepatic impairment. Consult a physician before use during pregnancy or lactation.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Teneligliptin 20mg + Metformin Hydrochloride 500mg SR Bilayered Tablet in the PCD pharma franchise market?

Teneligliptin 20mg + Metformin Hydrochloride 500mg SR Bilayered Tablet has strong demand in the diabetology, endocrinology, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-diabetic and chronic care portfolios.

Why should medical distributors include Teneligliptin 20mg + Metformin Hydrochloride 500mg SR Bilayered Tablet in their product range?

Bilayered Tablet in their product range? Medical distributors and agencies can benefit from consistent demand for Type 2 diabetes management under medical supervision. Teneligliptin 20mg is a DPP-4 inhibitor that improves glycemic control by increasing incretin activity, promoting glucose-dependent insulin secretion, and reducing glucagon release Metformin Hydrochloride 500mg Sustained Release (SR) helps lower blood glucose by reducing hepatic glucose production, improving insulin sensitivity, and enhancing peripheral glucose utilization The combination provides complementary mechanisms of action to help control fasting and postprandial blood glucose levels in adults with Type 2 Diabetes Mellitus, along with diet and exercise The bilayered sustained-release formulation allows controlled release of metformin while providing convenient once-daily dosing, improving patient compliance and gastrointestinal tolerability compared with immediate-release formulations in appropriate patients Long-term glycemic control helps reduce the risk of diabetes-related complications affecting the heart, kidneys, eyes, and nerves when used as part of a comprehensive diabetes management plan Regular monitoring of blood glucose, HbA1c, kidney function, and overall metabolic status is recommended during treatment. The medicine should be used only as prescribed by a qualified healthcare professional Frequently utilized in diabetology clinics, endocrinology departments, general medicine practices, and hospitals Widely prescribed by diabetologists, endocrinologists, and general physicians for long-term management of Type 2 Diabetes Mellitus This strengthens a comprehensive anti-diabetic and chronic care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Teneligliptin 20mg + Metformin Hydrochloride 500mg SR Bilayered Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent prescription demand, expanding diabetes care market opportunities, long-term therapy requirements, reliable supply chain support, repeat business, and attractive margins in the anti-diabetic segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality anti-diabetic pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.